ZOPISIGN 10 Tablet by Dr Precision is a high-potency pharmaceutical formulation containing 10 mg of Zopiclone, specifically created for the short-term management of moderate to severe insomnia. As a non-benzodiazepine cyclopyrrolone hypnotic, this medication acts rapidly within 30 minutes to modulate GABA-A receptors in the brain, enhancing sleep induction and maintenance without causing significant next-day sedation. Manufactured under strict WHO-GMP and ISO-certified conditions by BluepillExpress, ZOPISIGN 10 ensures consistent dosage accuracy, quality, and patient safety. This tablet is particularly suitable for patients who exhibit inadequate response to lower doses of Zopiclone (3.75 mg or 7.5 mg), providing enhanced therapeutic effects with a reduced risk of dependence compared to benzodiazepines. Packaged in moisture-resistant blister packs, ZOPISIGN 10 is designed to meet the regulatory requirements of both domestic and international markets, ensuring stability and compliance. Ideal for hospital pharmacies, healthcare providers, and pharmaceutical distributors, this product offers a reliable solution for acute and transient insomnia caused by stress, jet lag, or other sleep disorders, under proper medical supervision. Usage guidelines emphasize its short-term application (7-14 days) to prevent tolerance, dependence, and rebound insomnia, with contraindications for patients with severe hepatic conditions or respiratory insufficiencies. BluepillExpress supports private-label manufacturing, bulk packaging, and compliance documentation, making ZOPISIGN 10 an optimal choice for global B2B pharmaceutical supply chains and healthcare sectors seeking quality insomnia treatment solutions.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Zopiclone 10 mg |
| Therapeutic Category | Non-benzodiazepine hypnotic for insomnia |
| Onset of Action | Within 30 minutes |
| Primary Use | Short-term treatment of moderate to severe insomnia |
| Manufacturing Standards | WHO-GMP and ISO certified |
| Packaging | Moisture-protected blister packs |
| Dosage Recommendation | Administered shortly before bedtime, 7-14 days course |
| Safety Profile | Reduced next-day sedation, fewer withdrawal symptoms than benzodiazepines |
| Contraindications | Hypersensitivity, severe hepatic insufficiency, sleep apnea |
| Manufacturer | BluepillExpress under Dr Precision label |
| Attributes | Description |
|---|---|
| Chemical Class | Cyclopyrrolone |
| Mechanism of Action | Potentiation of GABA-A receptors enhancing inhibitory neurotransmission |
| Half-life | Short elimination half-life to reduce residual effects |
| Common Side Effects | Metallic taste, dry mouth, transient dizziness |
| Storage Conditions | Store in a cool, dry place away from moisture |
| Regulatory Compliance | Suitable for export with full documentation including COAs and stability data |
| Formulation Type | Tablet |
| Intended Use Duration | 7 to 14 days only |
| Packaging Type | Blister pack |
| Labeling Options | Domestic, export, private-label available |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ZOPISIGN 10 mg is preferred for patients who have not achieved adequate sleep improvement with lower doses such as 3.75 mg or 7.5 mg, particularly those with moderate to severe insomnia requiring enhanced therapeutic effects.
It should be used under strict medical supervision limiting use to 7-14 days to avoid dependence, and is contraindicated in patients with severe hepatic impairment, sleep apnea syndrome, or hypersensitivity to Zopiclone.
Due to its relatively short elimination half-life and distinct chemical structure, ZOPISIGN 10 provides effective sleep induction with reduced residual sedation and grogginess the following day.
ZOPISIGN 10 is supplied in moisture-protected blister packs, with labeling complying with domestic and international regulatory requirements, supported by comprehensive documentation such as COAs and stability data for seamless export.
No, concomitant use with alcohol, opioids, or other central nervous system depressants is contraindicated due to the risk of enhanced sedation and respiratory depression.
Country Of Origin: India
ZOPISIGN 10 Tablet contains Zopiclone 10 mg, a non-benzodiazepine hypnotic used for short-term management of severe insomnia. Known for its fast onset and improved sleep quality, it provides reliable relief from sleep disturbances with reduced next-day sedation. Manufactured under certified facilities, ZOPISIGN 10 ensures consistent efficacy, patient comfort, and safety compliance for global markets.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
ZOPISIGN 10 Tablet is a powerful pharmaceutical solution formulated with Zopiclone 10 mg, designed for the short-term treatment of insomnia and other sleep initiation or maintenance disorders. Zopiclone is a cyclopyrrolone-class hypnotic that works by modulating the GABA-A receptors in the brain, increasing the duration and quality of sleep. As a fast-acting sedative-hypnotic, ZOPISIGN 10 is effective in helping patients fall asleep quickly, stay asleep longer, and enjoy uninterrupted, restorative sleep throughout the night.
The 10 mg strength is typically reserved for patients who have not responded adequately to lower doses such as Zopiclone 3.75 mg or 7.5 mg. ZOPISIGN 10 is generally administered shortly before bedtime and begins acting within 30 minutes, making it highly effective for those suffering from acute insomnia, jet lag, stress-induced sleep disruptions, or transient sleep disorders.
ZOPISIGN 10 Tablet is produced in WHO-GMP and ISO-certified manufacturing environments by BluepillExpress, adhering to rigorous global quality standards. Each tablet is precisely formulated to deliver accurate dosage and consistent performance, meeting international pharmacopoeial specifications. This ensures that the final product remains stable, effective, and safe throughout its shelf life. It is available in moisture-protected blister packs, labeled for both domestic and international regulatory compliance.
The mechanism of Zopiclone involves potentiation of GABA, the brain’s primary inhibitory neurotransmitter. Unlike benzodiazepines, Zopiclone has a distinct chemical structure but exerts similar therapeutic effects with fewer withdrawal symptoms and reduced potential for dependence when used under medical supervision. The 10 mg dosage offers enhanced therapeutic efficacy, particularly in individuals with higher tolerance or more severe insomnia, while maintaining a relatively short elimination half-life to limit residual sedation or grogginess the following day.
ZOPISIGN 10 is generally well tolerated when taken as prescribed. Common side effects include a metallic or bitter taste, dry mouth, or transient dizziness. The formulation is not meant for long-term use and should be limited to short courses lasting 7 to 14 days. Prolonged or unsupervised use can lead to tolerance, dependence, or rebound insomnia. Hence, patient assessment and monitoring are essential for safe use. ZOPISIGN 10 should not be taken alongside alcohol, opioids, or other CNS depressants as it may potentiate sedation and respiratory depression.
ZOPISIGN 10 is contraindicated in patients with a history of hypersensitivity to Zopiclone or related compounds, as well as those with severe hepatic insufficiency, sleep apnea syndrome, myasthenia gravis, or acute pulmonary insufficiency. It should be used with caution in elderly patients or those with renal or hepatic impairment. Its use during pregnancy and lactation is not recommended unless explicitly advised by a physician due to limited safety data.
BluepillExpress delivers ZOPISIGN 10 Tablets with comprehensive third-party manufacturing services, including private-label branding, bulk packaging, and country-specific labeling solutions. The product is eligible for export to regulated and semi-regulated markets, with full documentation support such as COAs, stability data, and DMF assistance where applicable.
The efficacy, pharmacokinetic profile, and tolerability of ZOPISIGN 10 make it a preferred choice among healthcare providers for patients suffering from moderate to severe sleep disturbances. BluepillExpress ensures seamless scalability in production, precise formulation, and packaging in compliance with national and international drug authorities, making ZOPISIGN 10 an ideal product for inclusion in hospital pharmacies, online health platforms, and retail distribution chains.
ZOPISIGN 10 Tablet remains one of the most trusted pharmaceutical interventions for managing short-term insomnia, combining efficacy and safety in a single-dose unit. Whether intended for local market distribution or international expansion, BluepillExpress guarantees high-quality manufacturing and prompt supply to meet global demand.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
